|
|
||||||||
The Journal of Immunology, Vol 154, Issue 5 2434-2440, Copyright © 1995 by American Association of Immunologists
ARTICLES |
V Casini-Raggi, L Kam, YJ Chong, C Fiocchi, TT Pizarro and F Cominelli
Department of Medicine, University of Southern California, School of Medicine, Los Angeles 90033.
The etiology and pathogenesis of inflammatory bowel disease (IBD) are unknown. Increasing evidence supports the theory that chronic IBD is the result of dysfunctional immunoregulation manifested by an inappropriate production of mucosal cytokines. The aim of the present study was to test the hypothesis that a specific mucosal imbalance of IL-1 and IL-1 receptor antagonist (IL-1ra) production plays an important role in the perpetuation and chronicity of intestinal inflammation. Total IL-1, IL-1ra, and the IL-1ra/IL-1 ratio were measured in freshly isolated intestinal mucosal cells, as well as in mucosal biopsies obtained from control, Crohn's disease, and ulcerative colitis patients. IL-1 alpha, IL-1 beta, and IL-1 ra were measured by specific non-cross-reacting radioimmunoassays and ELISA. A markedly significant decrease in the intestinal mucosal IL-1ra/IL-1 ratio was found in both Crohn's disease and ulcerative colitis patients when compared with control subjects (p < 0.01). The IL-1ra/IL-1 ratio correlated closely with the clinical severity of disease (r = -0.7846, p < 0.001). Furthermore, the observed decrease in the IL-1ra/IL-1 ratio was specific for IBD because a decreased IL-1ra/IL-1 ratio was not found in patients with self-limiting colitis. These results support the hypothesis that an imbalance between IL-1 and IL-1ra production is of pathogenic importance in chronic inflammatory diseases, including IBD.
This article has been cited by other articles:
![]() |
H. Loppnow, K. Werdan, and M. Buerke Invited review: Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms Innate Immunity, April 1, 2008; 14(2): 63 - 87. [Abstract] [PDF] |
||||
![]() |
M. Chamekh, A. Phalipon, R. Quertainmont, I. Salmon, P. Sansonetti, and A. Allaoui Delivery of Biologically Active Anti-Inflammatory Cytokines IL-10 and IL-1ra In Vivo by the Shigella Type III Secretion Apparatus J. Immunol., March 15, 2008; 180(6): 4292 - 4298. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Al-Sadi and T. Y. Ma IL-1beta Causes an Increase in Intestinal Epithelial Tight Junction Permeability J. Immunol., April 1, 2007; 178(7): 4641 - 4649. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Trifonova, J.-M. Pasicznyk, and R. N. Fichorova Biocompatibility of Solid-Dosage Forms of Anti-Human Immunodeficiency Virus Type 1 Microbicides with the Human Cervicovaginal Mucosa Modeled Ex Vivo Antimicrob. Agents Chemother., December 1, 2006; 50(12): 4005 - 4010. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Cao, C. Fiocchi, and V. E. Pricolo Production of IL-1{beta}, hydrogen peroxide, and nitric oxide by colonic mucosa decreases sigmoid smooth muscle contractility in ulcerative colitis Am J Physiol Cell Physiol, December 1, 2005; 289(6): C1408 - C1416. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Simitsopoulou, E. Roilides, J. Dotis, M. Dalakiouridou, F. Dudkova, E. Andreadou, and T. J. Walsh Differential Expression of Cytokines and Chemokines in Human Monocytes Induced by Lipid Formulations of Amphotericin B Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1397 - 1403. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ashare, L. S. Powers, N. S. Butler, K. C. Doerschug, M. M. Monick, and G. W. Hunninghake Anti-inflammatory response is associated with mortality and severity of infection in sepsis Am J Physiol Lung Cell Mol Physiol, April 1, 2005; 288(4): L633 - L640. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Cao, L. Cheng, J. Behar, C. Fiocchi, P. Biancani, and K. M. Harnett Proinflammatory cytokines alter/reduce esophageal circular muscle contraction in experimental cat esophagitis Am J Physiol Gastrointest Liver Physiol, December 1, 2004; 287(6): G1131 - G1139. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Cao, M. D. Vrees, F. M. Potenti, K. M. Harnett, C. Fiocchi, and V. E. Pricolo Interleukin 1{beta}-Induced Production of H2O2 Contributes to Reduced Sigmoid Colonic Circular Smooth Muscle Contractility in Ulcerative Colitis J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 60 - 70. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Shifflett, F. G. Bottone Jr., K. M. Young, A. J. Moeser, S. L. Jones, and A. T. Blikslager Neutrophils augment recovery of porcine ischemia-injured ileal mucosa by an IL-1{beta}- and COX-2-dependent mechanism Am J Physiol Gastrointest Liver Physiol, July 1, 2004; 287(1): G50 - G57. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Alzoghaibi, S. W. Walsh, A. Willey, D. R. Yager, A. A. Fowler III, and M. F. Graham Linoleic acid induces interleukin-8 production by Crohn's human intestinal smooth muscle cells via arachidonic acid metabolites Am J Physiol Gastrointest Liver Physiol, April 1, 2004; 286(4): G528 - G537. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Nikolaus, P Rutgeerts, R Fedorak, A H Steinhart, G E Wild, D Theuer, J Mohrle, and S Schreiber Interferon {beta}-1a in ulcerative colitis: a placebo controlled, randomised, dose escalating study Gut, September 1, 2003; 52(9): 1286 - 1290. [Abstract] [Full Text] |
||||
![]() |
C. Linard, A. Ropenga, M. C. Vozenin-Brotons, A. Chapel, and D. Mathe Abdominal irradiation increases inflammatory cytokine expression and activates NF-{kappa}B in rat ileal muscularis layer Am J Physiol Gastrointest Liver Physiol, August 8, 2003; 285(3): G556 - G565. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bamba, A. Andoh, H. Yasui, J. Makino, S. Kim, and Y. Fujiyama Regulation of IL-11 expression in intestinal myofibroblasts: role of c-Jun AP-1- and MAPK-dependent pathways Am J Physiol Gastrointest Liver Physiol, August 8, 2003; 285(3): G529 - G538. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. P. Singh, S. Singh, D. D. Taub, and J. W. Lillard Jr. Inhibition of IFN-{gamma}-Inducible Protein-10 Abrogates Colitis in IL-10-/- Mice J. Immunol., August 1, 2003; 171(3): 1401 - 1406. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Pessi, J Karjalainen, J Hulkkonen, M M Nieminen, and M Hurme A common IL-1 complex haplotype is associated with an increased risk of atopy J. Med. Genet., May 1, 2003; 40(5): e66 - 66. [Full Text] [PDF] |
||||
![]() |
K-A Gwee, S M Collins, N W Read, A Rajnakova, Y Deng, J C Graham, M W McKendrick, and S M Moochhala Increased rectal mucosal expression of interleukin 1{beta} in recently acquired post-infectious irritable bowel syndrome Gut, April 1, 2003; 52(4): 523 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Rodriguez-Galan, C. Sotomayor, M. E. Costamagna, A. M. Cabanillas, B. S. Renteria, A. M. Masini-Repiso, and S. Correa Immunocompetence of macrophages in rats exposed to Candida albicans infection and stress Am J Physiol Cell Physiol, January 1, 2003; 284(1): C111 - C118. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Romero, M. A. Higgins, J. Gilmore, K. Boudreau, A. Maslen, H. J. Barker, and G. M. Kirby Down-Regulation of Alpha Class Glutathione S-Transferase by Interleukin-1beta in Human Intestinal Epithelial Cells (Caco-2) in Culture Drug Metab. Dispos., November 1, 2002; 30(11): 1186 - 1193. [Abstract] [Full Text] [PDF] |
||||
![]() |
P V Sivakumar, G M Westrich, S Kanaly, K Garka, T L Born, J M J Derry, and J L Viney Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage Gut, June 1, 2002; 50(6): 812 - 820. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Corbaz, T. ten Hove, S. Herren, P. Graber, B. Schwartsburd, I. Belzer, J. Harrison, T. Plitz, M. H. Kosco-Vilbois, S.-H. Kim, et al. IL-18-Binding Protein Expression by Endothelial Cells and Macrophages Is Up-Regulated During Active Crohn's Disease J. Immunol., April 1, 2002; 168(7): 3608 - 3616. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Y. PARK, R. B. GOODMAN, K. P. STEINBERG, J. T. RUZINSKI, F. RADELLA II, D. R. PARK, J. PUGIN, S. J. SKERRETT, L. D. HUDSON, and T. R. MARTIN Cytokine Balance in the Lungs of Patients with Acute Respiratory Distress Syndrome Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1896 - 1903. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Nemetz, M Toth, M A Garcia-Gonzalez, T Zagoni, J Feher, A S Pena, and Z Tulassay Allelic variation at the interleukin 1{beta} gene is associated with decreased bone mass in patients with inflammatory bowel diseases Gut, November 1, 2001; 49(5): 644 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Williams Inflammatory Cytokines and Mucosal Injury J Natl Cancer Inst Monographs, October 1, 2001; 2001(29): 26 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
M J Carter, F S di Giovine, S Jones, J Mee, N J Camp, A J Lobo, and G W Duff Association of the interleukin 1 receptor antagonist gene with ulcerative colitis in Northern European Caucasians Gut, April 1, 2001; 48(4): 461 - 467. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gabay, M. G. Dreyer, N. Pellegrinelli, R. Chicheportiche, and C. A. Meier Leptin Directly Induces the Secretion of Interleukin 1 Receptor Antagonist in Human Monocytes J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 783 - 791. [Abstract] [Full Text] |
||||
![]() |
L. Caradonna, L. Amati, T. Magrone, N.M. Pellegrino, E. Jirillo, and D. Caccavo Invited review: Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance Innate Immunity, June 1, 2000; 6(3): 205 - 214. [Abstract] [PDF] |
||||
![]() |
R Daig, G Rogler, E Aschenbrenner, D Vogl, W Falk, V Gross, J Scholmerich, and T Andus Human intestinal epithelial cells secrete interleukin-1 receptor antagonist and interleukin-8 but not interleukin-1 or interleukin-6 Gut, March 1, 2000; 46(3): 350 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Arondel, M. Singer, A. Matsukawa, A. Zychlinsky, and P. J. Sansonetti Increased Interleukin-1 (IL-1) and Imbalance between IL-1 and IL-1 Receptor Antagonist during Acute Inflammation in Experimental Shigellosis Infect. Immun., November 1, 1999; 67(11): 6056 - 6066. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Jarry, G Vallette, E Cassagnau, A Moreau, C Bou-Hanna, P Lemarre, E Letessier, J-C Le Neel, J-P Galmiche, and C L Laboisse Interleukin 1 and interleukin 1beta converting enzyme (caspase 1) expression in the human colonic epithelial barrier. Caspase 1 downregulation in colon cancer Gut, August 1, 1999; 45(2): 246 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Yoon, Z. Zhu, J. M. Gwaltney Jr., and J. A. Elias Rhinovirus Regulation of IL-1 Receptor Antagonist In Vivo and In Vitro: A Potential Mechanism of Symptom Resolution J. Immunol., June 15, 1999; 162(12): 7461 - 7469. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. T. Pizarro, M. H. Michie, M. Bentz, J. Woraratanadharm, M. F. Smith Jr., E. Foley, C. A. Moskaluk, S. J. Bickston, and F. Cominelli IL-18, a Novel Immunoregulatory Cytokine, Is Up-Regulated in Crohn's Disease: Expression and Localization in Intestinal Mucosal Cells J. Immunol., June 1, 1999; 162(11): 6829 - 6835. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Edelson, C. E. Bagwell, and H. J. Rozycki Circulating Pro- and Counterinflammatory Cytokine Levels and Severity in Necrotizing Enterocolitis Pediatrics, April 1, 1999; 103(4): 766 - 771. [Abstract] [Full Text] |
||||
![]() |
H. M. Schrijver, J. B. A. Crusius, B. M. J. Uitdehaag, M. A. Garcia Gonzalez, P. J. Kostense, C. H. Polman, and A. S. Pena Association of interleukin-1{beta} and interleukin-1 receptor antagonist genes with disease severity in MS Neurology, February 1, 1999; 52(3): 595 - 595. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Leach, N. J. Davidson, M. M. Fort, F. Powrie, and D. M. Rennick The Role of IL-10 in Inflammatory Bowel Disease: "Of Mice and Men" Toxicol Pathol, January 1, 1999; 27(1): 123 - 133. [Abstract] [PDF] |
||||
![]() |
H. Yang, W. Jiang, E. E. Furth, X. Wen, J. P. Katz, R. K. Sellon, D. G. Silberg, T. M. Antalis, C. W. Schweinfest, and G. D. Wu Intestinal inflammation reduces expression of DRA, a transporter responsible for congenital chloride diarrhea Am J Physiol Gastrointest Liver Physiol, December 1, 1998; 275(6): G1445 - G1453. [Abstract] [Full Text] [PDF] |
||||
![]() |
P C F Stokkers, B E van Aken, N Basoski, P H Reitsma, G N J Tytgat, and S J H van Deventer Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease Gut, July 1, 1998; 43(1): 33 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. F. Pender, J. M. E. Fell, S. M. Chamow, A. Ashkenazi, and T. T. MacDonald A p55 TNF Receptor Immunoadhesin Prevents T Cell-Mediated Intestinal Injury by Inhibiting Matrix Metalloproteinase Production J. Immunol., April 15, 1998; 160(8): 4098 - 4103. [Abstract] [Full Text] [PDF] |
||||
![]() |
I B Autenrieth, N Bucheler, E Bohn, G Heinze, and I Horak Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with bowel inflammation Gut, December 1, 1997; 41(6): 793 - 800. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Andus, R Daig, D Vogl, E Aschenbrenner, G Lock, S Hollerbach, M Kollinger, J Scholmerich, and V Gross Imbalance of the interleukin 1 system in colonic mucosa---association with intestinal inflammation and interleukin 1 receptor agonist genotype 2 Gut, November 1, 1997; 41(5): 651 - 657. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Hofbauer, T. Muhlberg, A. Konig, G. Heufelder, H.-D. Schworm, and A. E. Heufelder Soluble Interleukin-1 Receptor Antagonist Serum Levels in Smokers and Nonsmokers with Graves' Ophthalmopathy Undergoing Orbital Radiotherapy J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2244 - 2247. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Akeson, C. W. Woods, L. C. Hsieh, R. A. Bohnke, B. L. Ackermann, K. Y. Chan, J. L. Robinson, S. D. Yanofsky, J. W. Jacobs, R. W. Barrett, et al. AF12198, a Novel Low Molecular Weight Antagonist, Selectively Binds the Human Type I Interleukin (IL)-1 Receptor and Blocks in Vivo Responses to IL-1 J. Biol. Chem., November 29, 1996; 271(48): 30517 - 30523. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Mifflin, J. I. Saada, J. F. Di Mari, P. A. Adegboyega, J. D. Valentich, and D. W. Powell Regulation of COX-2 expression in human intestinal myofibroblasts: mechanisms of IL-1-mediated induction Am J Physiol Cell Physiol, April 1, 2002; 282(4): C824 - C834. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |